Literature DB >> 28473075

ACR Appropriateness Criteria® Osteoporosis and Bone Mineral Density.

Robert J Ward1, Catherine C Roberts2, Jenny T Bencardino3, Erin Arnold4, Steven J Baccei5, R Carter Cassidy6, Eric Y Chang7, Michael G Fox8, Bennett S Greenspan9, Soterios Gyftopoulos10, Mary G Hochman11, Douglas N Mintz12, Joel S Newman13, Charles Reitman14, Zehava S Rosenberg15, Nehal A Shah16, Kirstin M Small16, Barbara N Weissman17.   

Abstract

Osteoporosis is a considerable public health risk, with 50% of women and 20% of men >50 years of age experiencing fracture, with mortality rates of 20% within the first year. Dual x-ray absorptiometry (DXA) is the primary diagnostic modality by which to screen women >65 years of age and men >70 years of age for osteoporosis. In postmenopausal women <65 years of age with additional risk factors for fracture, DXA is recommended. Some patients with bone mineral density above the threshold for treatment may qualify for treatment on the basis of vertebral body fractures detected through a vertebral fracture assessment scan, a lateral spine equivalent generated from a commercial DXA machine. Quantitative CT is useful in patients with advanced degenerative bony changes in their spines. New technologies such as trabecular bone score represent an emerging role for qualitative assessment of bone in clinical practice. It is critical that both radiologists and referring providers consider osteoporosis in their patients, thereby reducing substantial morbidity, mortality, and cost to the health care system. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; DXA; fracture; osteoporosis; screening

Mesh:

Year:  2017        PMID: 28473075     DOI: 10.1016/j.jacr.2017.02.018

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  19 in total

1.  Prospective validation of a rapid CT-based bone mineral density screening method using colored spinal images.

Authors:  Elliot Varney; Asser Abou Elkassem; Majid Khan; Ellen Parker; Todd Nichols; David Joyner; Seth T Lirette; Candace Howard-Claudio; Andrew D Smith
Journal:  Abdom Radiol (NY)       Date:  2020-10-12

Review 2.  Update on Imaging-Based Measurement of Bone Mineral Density and Quality.

Authors:  Thomas M Link; Galateia Kazakia
Journal:  Curr Rheumatol Rep       Date:  2020-04-09       Impact factor: 4.592

Review 3.  Opportunistic Screening for Osteoporosis Using Computed Tomography: State of the Art and Argument for Paradigm Shift.

Authors:  Leon Lenchik; Ashley A Weaver; Robert J Ward; John M Boone; Robert D Boutin
Journal:  Curr Rheumatol Rep       Date:  2018-10-13       Impact factor: 4.592

4.  Low volumetric bone density is a risk factor for early complications after spine fusion surgery.

Authors:  Y Liu; A Dash; A Krez; H J Kim; M Cunningham; F Schwab; A Hughes; B Carlson; A Samuel; E Marty; H Moore; D J McMahon; J A Carrino; R S Bockman; E M Stein
Journal:  Osteoporos Int       Date:  2020-01-09       Impact factor: 4.507

5.  The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography.

Authors:  E Chiapparelli; I Okano; D Adl Amini; J Zhu; S N Salzmann; E T Tan; M Moser; O C Sax; C Echeverri; L Oezel; J Shue; A A Sama; F P Cammisa; F P Girardi; A P Hughes
Journal:  Osteoporos Int       Date:  2022-08-06       Impact factor: 5.071

6.  Fully automated radiomic screening pipeline for osteoporosis and abnormal bone density with a deep learning-based segmentation using a short lumbar mDixon sequence.

Authors:  Yinxia Zhao; Tianyun Zhao; Shenglan Chen; Xintao Zhang; Mario Serrano Sosa; Jin Liu; Xianfu Mo; Xiaojun Chen; Mingqian Huang; Shaolin Li; Xiaodong Zhang; Chuan Huang
Journal:  Quant Imaging Med Surg       Date:  2022-02

7.  Screening to prevent fragility fractures among adults 40 years and older in primary care: protocol for a systematic review.

Authors:  Michelle Gates; Jennifer Pillay; Guylène Thériault; Heather Limburg; Roland Grad; Scott Klarenbach; Christina Korownyk; Donna Reynolds; John J Riva; Brett D Thombs; Gregory A Kline; William D Leslie; Susan Courage; Ben Vandermeer; Robin Featherstone; Lisa Hartling
Journal:  Syst Rev       Date:  2019-08-23

8.  The prevalence and incidence of vertebral fractures in end-stage renal disease and the role of parathyroid hormone.

Authors:  T T Jansz; N A Goto; A J van Ballegooijen; H C Willems; M C Verhaar; B C van Jaarsveld
Journal:  Osteoporos Int       Date:  2019-11-14       Impact factor: 4.507

9.  Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway.

Authors:  Ying-Shan Shen; Xiao-Jun Chen; Sha-Na Wuri; Fan Yang; Feng-Xiang Pang; Liang-Liang Xu; Wei He; Qiu-Shi Wei
Journal:  Stem Cell Res Ther       Date:  2020-05-27       Impact factor: 6.832

10.  Proximal femur fat fraction variation in healthy subjects using chemical shift-encoding based MRI.

Authors:  Pedro Augusto Gondim Teixeira; Tanguy Cherubin; Sammy Badr; Adrien Bedri; Romain Gillet; Eliane Albuisson; Alain Blum
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.